SCHEMBL23716792

SCHEMBL23716792

N#CCN(C(=O)c1cccc(NC(=O)c2ccccc2)c1F)c1c(Cl)cc(C(F)(C(F)(F)F)C(F)(F)F)cc1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 7/20 0.39
MAPK13 O15264 1/20 0.37
MAPK12 P53778 1/20 0.37
MAPK11 Q15759 1/20 0.37
MAPK14 Q16539 1/20 0.37
MRGPRX4 Q96LA9 1/20 0.36
TRPV1 Q8NER1 1/20 0.36
PPARG P37231 2/20 0.36
NR1H4 Q96RI1 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
PPARD Q03181 1/20 0.35
PPARA Q07869 1/20 0.35
POLQ O75417 1/20 0.35
MEN1 O00255 1/20 0.35
PKM P14618 1/20 0.35
KMT2A Q03164 1/20 0.35
KCNK3 O14649 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21563474 0.94 RXFP1 (0.36) RXFP1MAPK13MAPK12MAPK11MAPK14
SCHEMBL21563712 0.90 RXFP1 (0.39) RXFP1PPARGNR1H4PPARDPPARA
SCHEMBL23716793 0.87 GAA (0.38) RXFP1PPARGNR1H4PPARAMAPT
SCHEMBL23086317 0.78 RXFP1 (0.49) RXFP1MAPK13MAPK12MAPK11MAPK14
SCHEMBL23716447 0.77 GPBAR1 (0.36) RXFP1MRGPRX4TRPV1POLQKCNK3
SCHEMBL29409939 0.77 GAA (0.41) RXFP1PPARGNR1H4CYP1A2CYP2D6
SCHEMBL1766984 0.74 RXFP1 (0.45) RXFP1MAPK13MAPK12MAPK11MAPK14
SCHEMBL21563800 0.74 GPBAR1 (0.34) MRGPRX4TRPV1POLQMEN1KMT2A
SCHEMBL23716448 0.74 GPBAR1 (0.36) POLQ
SCHEMBL12548713 0.73 RXFP1 (0.38) RXFP1PPARGNR1H4PPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210238126-A1 Benzamide Compound and Use Thereof METISA BIOTECHNOLOGY CO.,LTD. (CN) 2021-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210238126-A1 Benzamide Compound and Use Thereof TMBIM6, BCHE, DDT RXFP1 3251/4885MAPK13 1689/4885MAPK12 2416/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.